Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Fenofibrate from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., updating the approved generic product.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.,)
FDA approved a supplemental application for Fenofibrate submitted by Cipla USA Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for fenofibrate by Glenmark Pharmaceuticals Inc., USA under ANDA205566, resulting in updated labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Fenofibrate (FENOFIBRATE) submitted by Bostal LLC under ANDA207805.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for fenofibrate submitted by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for fenofibrate from Ajanta Pharma USA Inc., indicating an approved change to the generic produc…
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for fenofibrate submitted by Leading Pharma, LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for fenofibrate.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for fenofibrate by Chartwell RX, LLC.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for fenofibrate submitted by NorthStar RxLLC.
-
FDA approval · 2021-06-03FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate (ANDA 204019).
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fenofibrate from Alembic Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for fenofibrate submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's supplemental application for fenofibrate (generic) under ANDA210782. The approval pertains to…
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for fenofibrate from Dr. Reddy's Laboratories, indicating an approved change to the product unde…
-
FDA approval · 2021-05-14FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for fenofibrate (Amneal Pharmaceuticals NY LLC) under an ANDA.
-
FDA approval · 2021-05-14FDA Approved: FENOFIBRATE — Supplemental Application (Leading Pharma, LLC)
The FDA approved a supplemental application for fenofibrate submitted by Leading Pharma, LLC.
-
FDA approval · 2021-03-08FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for Gemfibrozil (generic; Northstar RxLLC) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia. [Phase 3]
Phase 3 study reporting efficacy and safety of Omega-3-acid Ethyl Ester in Chinese adults with hypertriglyceridemia; study completed.
-
FDA approval · 2021-02-10FDA Approved: FENOFIBRATE — Original Application (Bostal LLC)
FDA approved the original application for fenofibrate by Bostal LLC, enabling the marketing of a generic fenofibrate product for lipid disor…
-
FDA approval · 2021-02-02FDA Approved: FENOFIBRATE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for fenofibrate submitted by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 study of ISIS 703802 in participants with hypertriglyceridemia, type 2 diabetes, and nonalcoholic fatty liver disease has completed …